ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,566,353 | +6683.7% | 335,278 | +7514.8% | 0.02% | – |
| Q2 2023 | $126,278 | -93.4% | 4,403 | -94.5% | 0.00% | -100.0% |
| Q1 2023 | $1,926,900 | +76.1% | 80,388 | +24.6% | 0.01% | +50.0% |
| Q4 2022 | $1,093,920 | -88.0% | 64,500 | -89.5% | 0.00% | -89.2% |
| Q3 2022 | $9,146,000 | -36.4% | 617,124 | -32.4% | 0.04% | -39.3% |
| Q2 2022 | $14,376,000 | +25.4% | 913,323 | +114.8% | 0.06% | +32.6% |
| Q1 2022 | $11,463,000 | +10.0% | 425,200 | +90.7% | 0.05% | -32.4% |
| Q2 2020 | $10,424,000 | – | 223,013 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |